Overview

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
To compare efficacy and safety of Exubera® vs Lantus® in patients with type 2 diabetes mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Hypoglycemic Agents
Insulin
Insulin Glargine
Insulin, Globin Zinc